Applied Therapeutics Inc

Plains GP Hlds

Madrigal Pharmaceuticals

Akero Therapeutics Inc

Avidity Biosciences

Phathom Pharmaceuticals

TScan Therapeutics

Ardelyx

Abeona Therapeutics

Syndax Pharmaceuticals

Simplify Propel Opportunities ETF

SURI employs an actively managed, multi-asset strategy that focuses on equity and debt securities of companies in the healthcare sector. The fund selects securities believed to be attractive investment opportunities. Derivatives may also be used to leverage exposure and hedge against declines.

The Simplify Propel Opportunities ETF (SURI) is a healthcare-based fund that provides exposure to global fixed income and equity markets in the healthcare sector. SURI has a since-inception return of -13%, but its recent performance has shown potential for growth. The fund offers a near-13% yield from its distributions, making it an attractive option for investors looking for fixed-income plays in the healthcare sector.

Simplify Propel Opportunities ETF: Healthcare Likely To Rise Again In FY24 And Beyond

Simplify Aggregate Bond Plus Credit Hedge ETF

Simplify Stable Income ETF

Simplify High Yield PLUS Credit Hedge ETF

Simplify Opportunistic Income Etf

Simplify Managed Futures Strategy ETF

Simplify Tail Risk Strategy ETF

Simplify Market Neutral Equity Long/Short ETF

Simplify Macro Strategy ETF

Simplify Commodities Strategy No K-1 ETF

Simplify Hedged Equity ETF

Simplify Enhanced Income ETF

Simplify Bitcoin Strategy PLUS Income ETF

Simplify MBS ETF

Simplify Interest Rate Hedge ETF

Simplify Health Care ETF

Simplify Multi-Qis Alternative ETF

Simplify US Equity PLUS GBTC ETF

Simplify US Equity PLUS Downside Convexity ETF

Simplify US Equity PLUS QIS ETF

Simplify US Equity Plus Upside Convexity ETF

Simplify Volatility Premium ETF

Simplify Short Term Treasury Futures Strategy ETF

Simplify Risk Parity Treasury ETF

Simplify Volt RoboCar Disruption and Tech ETF

NEW YORK--(BUSINESS WIRE)--Simplify announced today that it expects to deliver capital gains distributions across six Simplify ETFs.

Simplify Provides Estimated Capital Gain Distribution Information for 2023

ALPS Medical Breakthroughs ETF

Virtus LifeSci Biotech Clinical Trials ETF

Loncar Cancer Immunotherapy ETF

Global X MSCI Nigeria ETF

Aberdeen Standard Physical Palladium Shares ETF 

iPath Series B Bloomberg Platinum Subindex Total Return ETN

GraniteShares Platinum Trust

Aberdeen Standard Physical Platinum Shares ETF

Invesco DWA Healthcare Momentum ETF

In a somewhat surprising turn, biotech and life sciences-focused ETFs were the driving themes in the last week's top-performing ETFs, with the ALPS Medical Breakthroughs ETF (SBIO) leading the way with a 10% return.

News for Simplify Propel Opportunities ETF ETF (SURI)